Pasithea Therapeutics KTTAW Growth Metrics (2022-2026)

NASDAQ KTTAW
$0.00 0.00 (-36.36%)
As of: Sep 9, 2026 · 3:56 PM EDT
Reported Financials

Pasithea Therapeutics Quarterly Growth Metrics

Periods 18 quarters
Latest Jun 2026

Pasithea Therapeutics growth metrics data for the quarter ended Jun 2026. These growth metrics cover 18 quarters of results from Mar 2022 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Growth Metrics Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Growth Ratios
EBITDA Margin (QoQ) -0.51M2.07M-0.02M
EBIT Margin (QoQ) -0.51M2.07M-0.02M
EBT Margin (QoQ) -0.80M1.75M-0.00M
FCF Margin (QoQ) 0.15M1.22M0.08M
Gross Margin (QoQ) -0.00M0.01M0.00M
Interest Coverage Ratio (QoQ)Interest Cover (QoQ) 106.50%
Net Margin (QoQ) -0.91M2.11M-0.16M
Operating Margin (QoQ) -0.51M2.07M-0.02M
Return on Assets [ROA] Growth (1y)ROA Growth (1y) -0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-287.00-81.000.00M0.01M0.00M
Return on Assets [ROA] Growth (3y)ROA Growth (3y) -0.01M-0.01M-0.01M-0.01M-0.00M0.00M0.00M
Return on Assets [ROA] (QoQ)ROA (QoQ) -90.00-463.00-536.00-0.00M-700.00-548.00-658.007.00-0.00M-0.00M-515.00713.00-844.00359.00-310.000.00M0.00M-555.00
Return on Capital Employed [ROCE] Growth (1y)ROCE Growth (1y) -0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-679.00-713.000.00M0.01M0.01M
Return on Capital Employed [ROCE] Growth (3y)ROCE Growth (3y) -0.01M-0.01M-0.01M-0.01M-0.00M-116.00-266.00
Return on Capital Employed [ROCE] (QoQ)ROCE (QoQ) -2.00-476.00-642.00-908.00-511.00-558.00-593.00-0.00M-0.00M-0.00M-149.00448.00-0.00M331.00-184.000.00M0.00M-708.00
Return on Sales [ROS] (QoQ)ROS (QoQ) -0.51M2.07M-0.02M